ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 34.2% | 36.0% | 37.9% | 37.1% | 38.6% | 38.6% | ||
| Changes by years, y/y, % | +2pp | +2pp | -1pp | +1pp | +3.0% | ||||
ОЗОН Фармацевтика. EBITDA margin, %
ОЗОН Фармацевтика. EBITDA margin, changes, pp
ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA margin, % | ? | 49.8% | 36.4% | 29.3% | 41.2% | 43.7% | 38.6% | |
| Changes by years, y/y, % | +12pp | +4pp | -3pp | +11pp | -6pp | |||
| Changes by quarters, q/q, % | +19pp | -13pp | -7pp | +12pp | +3pp | |||